Clinical Trial Update: Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating mitotane with or without cisplatin and etoposide after surgery in patients with Stage I-III adrenocortical carcinoma at high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Mitotane (mitotane)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma | Phase 3 | Status: RECRUITING